Integrating Circulating Tumor DNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
Demographics (3)
- AGE - Subject age at enrollment (phv00558668.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00558678.v1.p1)
- SEX - Biological sex (phv00558664.v1.p1)
Other (17)
- ANALYTE_TYPE - Analyte Type (phv00558675.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00558674.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body (phv00558663.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00558677.v1.p1)
- HISTOLOGY - Histologic subtype (phv00558670.v1.p1)
- IS_TUMOR - Tumor status (phv00558676.v1.p1)
- PFS_EVENT - Progression-free survival event (phv00558671.v1.p1)
- PFS_MONTHS - Progression-free survival time (phv00558672.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00558679.v1.p1)
- SAMPLE_ID - Sample ID (phv00558673.v1.p1)
- SAMPLE_ID - Sample ID (phv00558666.v1.p1)
- SAMPLE_TYPE - Type of sample (phv00558681.v1.p1)
- STAGE - AJCC 7th edition group stage (phv00558669.v1.p1)
- SUBJECT_ID - Subject ID (phv00558667.v1.p1)
- SUBJECT_ID - Subject ID (phv00558662.v1.p1)
- SUBJECT_ID - Subject ID (phv00558665.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00558680.v1.p1)